InnoTech Precision Medicine is proud to announce that it has been awarded a National Science Foundation (NSF) grant titled “Development of a Microfluidic Device for Multi-Omics Diagnosis of Cancer.” This prestigious award will accelerate the development of our innovative, saliva-based diagnostic platform for early cancer detection.

The focus of the NSF-funded project is the design and development of a novel microfluidic device that enables:

• Integrated Multi-Omics Analysis – Combining genomic, proteomic, and other biomarker data to provide comprehensive, accurate diagnostic insights.
• Saliva-Based Liquid Biopsy – A non-invasive approach that delivers lab-quality cancer detection in under 30 minutes, right at the point of care.
• AI-Powered Decision Support – Utilizing advanced machine learning algorithms to assist clinicians in real-time diagnosis and treatment planning.

We are also thrilled to announce that Professor Alexander Alexeev of Georgia Tech is a key collaborator on this project. His expertise in microfluidics and computational modeling brings crucial scientific depth to the development and optimization of the diagnostic platform.

The NSF’s support highlights the transformative potential of this work in making cancer detection faster, more accessible, and more accurate. This milestone reinforces InnoTech Precision Medicine’s commitment to innovating cancer diagnostics and ultimately improving patient outcomes.